TSXV/KMC.H (TSXV/KMC.H)

TSX Venture Exchange: TSXV/KMC.H · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	744K
Net income (ttm)	-130.9K
EPS (ttm)	-CA$0.00
Shares out	74.4M
Volume	0
Beta	1.93

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -130.9K
EPS (ttm): -CA$0.00
Market cap: 744K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/KMC.H indicators

Market & fundamental data

Available fields

Groups with data

Currency

USD

Showing 99 of 99 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Anguilla
Country code	CA
Earnings date	2026-10-30
Enterprise value	CAD 581,551
Exchange	TSX Venture Exchange
Financial currency	USD
Financial report date	2025-12-31
First seen	2026-05-10
Fiscal year end	June
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	AIG5300R1094
Last earnings date	2026-02-26
Last refreshed	2026-10-29
Market cap	CAD 743,971
Next earnings date	2026-10-30
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	9995
Stock price date	2026-07-29
Symbol	tsxv/KMC.H

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-18.77%
Industry forward P/E	34.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-20.73%
ROA (5Y)	-7,318.62%
ROCE	87.07%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -101,180
EPS	CAD -0.00
Net cash flow	CAD -74,823
Net income	CAD -130,905
Operating income	CAD -101,180

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.00
Long-term assets	CAD -5,698
Long-term liabilities	CAD -8,171
Net cash (debt)	CAD 162,419
Net cash / market cap	21.83%
Net cash growth	-32.47%
Piotroski F-Score	2
Shareholders' equity	CAD -116,207
Tangible book value	CAD -116,207
Tangible book value per share	CAD -0.00
Total assets	CAD 267,637
Total cash	CAD 267,637
Total debt	CAD 105,218
Total liabilities	CAD 383,844
WACC	13.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 273,335
Current liabilities	CAD 392,015
Current ratio	0.7
Net working capital	CAD -278,625
Quick ratio	0.7
Working capital	CAD -116,207

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-48.01%
Shareholder yield	-48.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1Y price change	-90.91%
1Y return CAGR	-90.92%
1Y total return	-90.91%
20-day SMA	CAD 0.04
3Y price change	-66.67%
3Y return CAGR	-30.66%
3Y total return	-66.67%
50-day SMA	CAD 0.09
52-week high	CAD 0.13
52-week high date	2025-08-06
52-week low	CAD 0.01
52-week low date	2026-07-29
6M price change	-66.67%
6M total return	-66.67%
All-time high	CAD 0.14
All-time high date	2025-06-05
All-time low	CAD 0.01
All-time low date	2026-04-28
Average true range (ATR)	CAD 0.01
Average volume	118.2K
Beta (1Y)	-0.96
Beta (2Y)	-0.38
Beta (5Y)	1.93
Change from 52-week high	-92.31%
Change from 52-week low	0%
Change from all-time high	-92.86%
Change from all-time low	0%
Monthly RSI	38.83
Previous close	CAD 0.01
Price vs 20-day SMA	-74.49%
Price vs 50-day SMA	-88.53%
Relative volume	0.08
RSI	23.57
Sharpe ratio	0.1
Sortino ratio	0.17
Volume	0
Weekly RSI	0
YTD price change	-66.67%
YTD total return	-66.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	30.45%
Shares change (YoY)	48.01%
Shares outstanding	74.4M

Deeper analysis on TSXV/KMC.H

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/KMC.H report

Is a complete TSXV/KMC.H research report available?

No complete published report is available for tsxv/KMC.H (TSXV/KMC.H) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/KMC.H (TSXV/KMC.H)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/KMC.H

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/KMC.H indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/KMC.H

Frequently asked questions